LDB2 Antibody / LIM domain binding 2, Clone: [PCRP-LDB2-1B10], Mouse, Monoclonal

Artikelnummer: NSJ-V5043-100UG
Artikelname: LDB2 Antibody / LIM domain binding 2, Clone: [PCRP-LDB2-1B10], Mouse, Monoclonal
Artikelnummer: NSJ-V5043-100UG
Hersteller Artikelnummer: V5043-100UG
Alternativnummer: NSJ-V5043-100UG
Hersteller: NSJ Bioreagents
Wirt: Mouse
Kategorie: Antikörper
Applikation: FACS, IF, IHC-P
Spezies Reaktivität: Human
Immunogen: Recombinant full-length human LDB2 protein was used as the immunogen for the LDB2 antibody.
The LIM-only (LMO) proteins, LMO1 and LMO2, are nuclear factors that are characterized by a conserved LIM domain. The LIM domain consists of a cysteine-rich zinc-binding motif that is present in a variety of transcription factors, including the LIM homeobox (LHX) proteins expressed in the central nervous system and involved in cell differentiation. LMO1 and LMO2 are expressed in the adult CNS in a cell type-specific manner, where they are differentially regulated by neuronal activity and are involved in regulating the cellular differentiated phenotype of neurons. LMO2 lacks a specific DNA-binding homeobox domain but rather assembles into transcriptional regulatory complexes to mediate gene expression by interacting with the widely expressed nuclear LIM interactor (NLI). NLI, known also as CLIM-1, and the related protein CLIM-2 facilitate the formation of heteromeric LIM complexes and also enhance the nuclear retention of LIM proteins. LMO2 and the related protein LMO4 are expressed in thymic precursor cells. LMO4 is also expressed in mature T cells, cranial neural crest cells, somite, dorsal limb bud mesenchyme, motor neurons, and Schwann cell progenitors.
Klonalität: Monoclonal
Klon-Bezeichnung: [PCRP-LDB2-1B10]
UniProt: O43679
Reinheit: Protein A/G affinity
Formulierung: 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Antibody Type: Primary Antibody
Application Verdünnung: Flow cytometry: 1-2ug/million cells,Immunofluorescence: 1-2ug/ml,Immunohistochemistry (FFPE): 1-2ug/ml for 30 min at RT
Anwendungsbeschreibung: Optimal dilution of the LDB2 antibody should be determined by the researcher.